Table 1. Clinical characteristics and median E6 load for LSIL of 61 eligible women with LSILs due to HPV 16, 18, 52, or 58 with at least four follow-up visits.
| HPV 16 | HPV 18 | HPV 52 | HPV 58 | |
|---|---|---|---|---|
| Percentage of each type | 23.0% (14/61) | 13.1% (8/61) | 42.6% (26/61) | 21.3% (13/61) |
| Median age (range) | 35 (range: 24–58) | 31 (range: 23–51) | 41 (range: 24–65) | 38 (range: 20–52) |
| Median E6 load for LSIL | 13 437 | 26 599 | 35 620 | 37 366 |
| Range of viral load for LSIL | 0–735 527 | 0–5 029 143 | 0–3 843 486 | 0–2 754 113 |
| Median E6 load for HSIL | 31 916 | 21 067 | 156 906 | 110 107 |
| Range of viral load for HSIL | 0–34 386 322 | 0–41 748 | 0–13 596 437 | 0–14 243 132 |
| P-value (median E6 load between LSIL and HSIL) | 0.049 | 0.499 | 0.032 | 0.184 |
HSILs=high-grade squamous intraepithelial lesions.